Jean P. Delord

1, Avenue Irène Joliot Curie, 31059 Toulouse Cedex 9
Toulouse, 31059, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.

Journal: International journal of cancer
Published: December 05, 2024

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.

Journal: Investigational new drugs
Published: April 20, 2023

5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC).

5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC).

Journal: Bulletin du cancer
Published: May 22, 2022

Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers.

Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers.

Journal: Oncoimmunology
Published: November 01, 2021

Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.

Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.

Journal: Current oncology (Toronto, Ont.)
Published: April 07, 2021

DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.

DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.

Journal: Scientific reports
Published: August 01, 2018

Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance.

Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance.

Journal: Oncotarget
Published: November 27, 2017

Fluorescence-guided surgery for cancer patients: a proof of concept study on human xenografts in mice and spontaneous tumors in pets.

Fluorescence-guided surgery for cancer patients: a proof of concept study on human xenografts in mice and spontaneous tumors in pets.

Journal: Oncotarget
Published: July 27, 2017

Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.

Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.

Journal: JAMA dermatology
Published: May 25, 2017

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies.

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies.

Journal: Current opinion in oncology
Published: May 03, 2016

Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series.

Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series.

Journal: Breast cancer research and treatment
Published: May 10, 2014

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.

Journal: British journal of clinical pharmacology
Published: February 04, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026